BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33390842)

  • 1. MYC dysfunction modulates stemness and tumorigenesis in breast cancer.
    Liu Y; Zhu C; Tang L; Chen Q; Guan N; Xu K; Guan X
    Int J Biol Sci; 2021; 17(1):178-187. PubMed ID: 33390842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
    Guo L; Li F; Liu H; Kong D; Chen C; Sun S
    J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop.
    Ma F; Liu X; Zhou S; Li W; Liu C; Chadwick M; Qian C
    Cancer Lett; 2019 May; 450():63-75. PubMed ID: 30771425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
    Xu LZ; Li SS; Zhou W; Kang ZJ; Zhang QX; Kamran M; Xu J; Liang DP; Wang CL; Hou ZJ; Wan XB; Wang HJ; Lam EW; Zhao ZW; Liu Q
    Oncogene; 2017 Jan; 36(3):304-317. PubMed ID: 27345399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
    Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
    Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The small nucleolar RNA SNORA51 enhances breast cancer stem cell-like properties via the RPL3/NPM1/c-MYC pathway.
    Li S; Jin Z; Song X; Ma J; Peng Z; Yu H; Song J; Zhang Y; Sun X; He M; Yu X; Jin F; Zheng A
    Mol Carcinog; 2024 Jun; 63(6):1117-1132. PubMed ID: 38421204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
    Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
    J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
    Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
    J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer.
    Gupta N; Jung K; Wu C; Alshareef A; Alqahtani H; Damaraju S; Mackey JR; Ghosh S; Sabri S; Abdulkarim BS; Bigras G; Lai R
    Oncotarget; 2017 Apr; 8(17):28101-28115. PubMed ID: 28427212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
    He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
    Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
    Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A
    Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triterpene Acid (
    Choi HS; Kim SL; Kim JH; Deng HY; Yun BS; Lee DS
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.
    Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM
    Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.
    Nair R; Roden DL; Teo WS; McFarland A; Junankar S; Ye S; Nguyen A; Yang J; Nikolic I; Hui M; Morey A; Shah J; Pfefferle AD; Usary J; Selinger C; Baker LA; Armstrong N; Cowley MJ; Naylor MJ; Ormandy CJ; Lakhani SR; Herschkowitz JI; Perou CM; Kaplan W; O'Toole SA; Swarbrick A
    Oncogene; 2014 Jul; 33(30):3992-4002. PubMed ID: 24056965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
    Suo HD; Tao Z; Zhang L; Jin ZN; Li XY; Ma W; Wang Z; Qiu Y; Jin F; Chen B; Cao Y
    Biomed Res Int; 2020; 2020():7575862. PubMed ID: 32766313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.